NEURO NEWS
Neurological News with information about conditions, treatments, current studies and breakthroughs.
Improving Motor Function: TMS Therapy for Cerebral Palsy at Countryside Neurology
Discover the potential of Transcranial Magnetic Stimulation (TMS) in enhancing motor function for individuals with cerebral palsy. Explore advanced therapies [...]
Advancing Recovery: TMS Therapy for Traumatic Brain Injury at Countryside Neurology
Discover how Transcranial Magnetic Stimulation (TMS) offers hope for traumatic brain injury (TBI) recovery. Learn about innovative therapies available at [...]
Transforming Migraine Relief with TMS Therapy at Countryside Neurology
Explore the groundbreaking potential of Transcranial Magnetic Stimulation (TMS) for alleviating migraines. Discover how Countryside Neurology in Palm Harbor, FL, [...]
TMS Eases Hundreds of Daily Seizures: How TMS Therapy at Countryside Neurology Can Help
Transcranial Magnetic Stimulation (TMS) therapy has emerged as a groundbreaking treatment for various neurological and psychiatric conditions, offering new hope [...]
TMS Therapy for Auditory Hallucinations in Schizophrenia: A Promising Treatment at Countryside Neurology
Schizophrenia is a complex mental health disorder characterized by a range of symptoms, including auditory hallucinations—hearing voices that are not [...]
TMS Therapy for Tinnitus Relief at Countryside Neurology: Recent Research
Tinnitus, often described as a persistent ringing in the ears, affects millions of people worldwide. This condition can significantly impact [...]
- Medicinal Signaling Cell Therapy Fast Tracked for Mild Alzheimer Disease July 29, 2024The investigational allogeneic cellular therapy is believed to impart anti-inflammatory, pro-vascular, and pro-regenerative effects.
- Endo Recalls Clonazepam ODT Due to Carton Label Displaying Incorrect Strength July 29, 2024The product is being recalled because the incorrect strength of 0.125mg is appearing on the carton labels.
- Investigational Gene Therapy for Parkinson Disease Gets Fast Track Status July 22, 2024AB-1005 is an investigational gene therapy based on AAV2 containing the human GDNF transgene.
- FDA Approves Aflibercept Biosimilar Ahzantive July 16, 2024Ahzantive is a vascular endothelial growth factor inhibitor.
- Ketamine May Reduce Cluster Headache Symptoms July 2, 2024Researchers sought to evaluate ketamine as a potentially promising treatment approach.
Get Social